DEF 14A: Shattuck Labs Sets Date for 2024 Annual Stockholders Meeting

Shattuck Labs will hold its 2024 Annual Meeting of Stockholders virtually on June 7, 2024, to elect directors and ratify the selection of its independent auditor.

Summary

• Shattuck Labs, Inc. will hold its 2024 Annual Meeting of Stockholders on June 7, 2024, at 11:30 a.m. Eastern Time, as a virtual meeting.
• Stockholders of record as of April 11, 2024, are entitled to notice of and to vote at the Annual Meeting.
• The meeting's purposes include electing three Class I director nominees to serve until the 2027 Annual Meeting and ratifying the selection of KPMG LLP as the company's independent registered public accounting firm for the year ending December 31, 2024.
• The Board of Directors recommends voting FOR the election of each director nominee and FOR the ratification of KPMG LLP as the independent auditor.
• The proxy materials were first made available to stockholders on or about April 23, 2024.
• As of the record date, 47,550,872 shares of common stock were issued and outstanding.

Sentiment

Score: 7

Explanation: The document is primarily informational and procedural, with a neutral to slightly positive sentiment due to the routine nature of the matters being addressed and the Board's recommendations.

Positives

• The Board recommends voting FOR all director nominees and FOR the ratification of the auditor selection.
• The company has adopted a virtual meeting format to provide a consistent experience to all stockholders regardless of geographic location.
• The company has a written related person transaction policy that sets forth procedures for the identification, review, consideration and approval or ratification of related person transactions.
• The company has adopted a Rule 10D-1 Clawback Policy, which is intended to comply with the requirements of Nasdaq Listing Standard 5608 implementing Rule 10D-1 under the Exchange Act.

Risks

• The Proxy Statement contains forward-looking statements that are subject to substantial risks and uncertainties.
• The company expressly disclaims any obligation to update or alter any statements whether as a result of new information, future events or otherwise, except as required by law.

Future Outlook

The Proxy Statement includes forward-looking statements regarding the company's Board of Directors, corporate governance practices, executive compensation program, and equity compensation utilization, which are subject to risks and uncertainties.

Industry Context

The document provides insight into Shattuck Labs' corporate governance and executive compensation practices, aligning with industry standards for publicly traded biotechnology companies. The virtual meeting format reflects a growing trend in corporate governance to enhance accessibility and reduce costs.

Comparison to Industry Standards

• The director compensation structure, including cash retainers and equity awards, is typical for publicly traded biotechnology companies of similar size and stage.
• The use of an independent compensation consultant (Aon) to review and recommend changes to director compensation aligns with best practices in corporate governance.
• The company's related person transaction policy and Code of Business Conduct and Ethics are consistent with industry standards for promoting transparency and ethical behavior.
• The company's Rule 10D-1 Clawback Policy is consistent with the requirements of Nasdaq Listing Standard 5608 implementing Rule 10D-1 under the Exchange Act.

Corporate Governance

Related Party Transactions

• On December 21, 2023, the Company entered into a Securities Purchase Agreement with certain entities affiliated with Redmile (the Purchasers), relating to the purchase of pre-funded warrants to purchase 3,100,823 shares of common stock at a purchase price of $6.4499 per pre-funded warrant, for aggregate gross proceeds of $19,999,998.30, before deducting offering expenses (the Private Placement).

Stakeholder Impact

• Shareholders are provided with the opportunity to vote on key corporate governance matters.
• The election of directors and ratification of the auditor directly impact the oversight and financial integrity of the company.
• Executive compensation decisions impact management's incentives and alignment with shareholder interests.

Next Steps

• Stockholders are encouraged to vote on the proposals outlined in the Proxy Statement.
• The company will announce preliminary voting results at the Annual Meeting and publish final results in a Current Report on Form 8-K.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Director Election, Auditor Ratification, Corporate Governance, Executive Compensation, Shattuck Labs, Stockholders